Add this topic to your myFT Digest for news straight to your inbox
New timetable from Competition and Markets Authority means $75bn transaction could be closed within weeks
Federal Trade Commission probes Microsoft-backed OpenAI over potential harm from chatbot’s fabricating information
Restructured transaction could trigger a fresh antitrust probe, warns Competition and Markets Authority
Competition watchdog has sought to prevent Big Tech from expanding its market power
UK competition watchdog also agrees to reopen talks on $75bn video games merger
Dealmakers say the information will be burdensome to collate and superfluous for vast majority of transactions
Antitrust agencies’ overhaul adds to growing checks on sector and will delay deals, say lawyers
Regulators take aim at Amazon and other companies over confusing websites that seek to maximise revenue
Claim comes in FTC court hearing over whether to put the brakes on huge gaming purchase
US regulator goes after ecommerce giant in its latest lawsuit against Big Tech
Federal Trade Commission had asked the court to stop $75bn acquisition from closing while it pursues a challenge
Competition regulator’s latest move poses yet more trouble for the tech merger
Antitrust challenge may force big pharma groups to rethink ‘pure play’ business models
Drugmakers’ appetite for takeovers surges but FTC action against Amgen raises risks for megadeals
Inquiry by US regulator focuses on whether manufacturers colluded in relation to programme for low-income families
The UK and US are emerging as the toughest enforcers of limits on technology takeovers
Plus, a chill descends on the biotech industry and Adani courts his bankers
Development chief raises worry over innovation after FTC sues to block Amgen-Horizon deal
The US trust buster’s opposition to the tie-up focuses on so-called pharmacy benefit managers
Leonard Schleifer supportive of FTC’s lawsuit against takeover of Horizon Therapeutics
Plus, boutique investment bank Raine pockets a huge fee and Deutsche Bank’s chair makes his mark
US regulator sues to block takeover of biotech group Horizon Therapeutics
Facebook parent pushes back against regulator’s proposal, calling it a ‘political stunt’
FTC warns acquisition would hurt competition in the market for early detection cancer tests
Yale academic was among the first to show that tech groups’ ‘free’ products could be anti-competitive
International Edition